UA129115C2 - Комбінована вакцина - Google Patents
Комбінована вакцина Download PDFInfo
- Publication number
- UA129115C2 UA129115C2 UAA201902890A UAA201902890A UA129115C2 UA 129115 C2 UA129115 C2 UA 129115C2 UA A201902890 A UAA201902890 A UA A201902890A UA A201902890 A UAA201902890 A UA A201902890A UA 129115 C2 UA129115 C2 UA 129115C2
- Authority
- UA
- Ukraine
- Prior art keywords
- contained
- amount
- type
- antigen
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201621029037 | 2016-08-26 | ||
| PCT/IB2017/055100 WO2018037365A1 (en) | 2016-08-26 | 2017-08-24 | Multivalent vaccine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA129115C2 true UA129115C2 (uk) | 2025-01-22 |
Family
ID=60083359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201902890A UA129115C2 (uk) | 2016-08-26 | 2017-08-24 | Комбінована вакцина |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11235054B2 (https=) |
| EP (1) | EP3503917B1 (https=) |
| JP (3) | JP7384667B2 (https=) |
| KR (1) | KR102607295B1 (https=) |
| CN (1) | CN110691611A (https=) |
| AU (1) | AU2017316768B2 (https=) |
| CA (1) | CA3032901A1 (https=) |
| CU (1) | CU24682B1 (https=) |
| EA (1) | EA201900117A1 (https=) |
| IL (1) | IL264605B2 (https=) |
| MX (1) | MX2019001780A (https=) |
| MY (1) | MY191163A (https=) |
| PE (1) | PE20200004A1 (https=) |
| PH (1) | PH12019500404B1 (https=) |
| SG (1) | SG11201900365WA (https=) |
| UA (1) | UA129115C2 (https=) |
| WO (1) | WO2018037365A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201900365WA (en) * | 2016-08-26 | 2019-02-27 | Serum Institute Of India Pvt Ltd | Multivalent vaccine composition |
| US11793873B2 (en) | 2017-05-10 | 2023-10-24 | University Of Massachusetts | Bivalent dengue/hepatitis B vaccines |
| MX2021004233A (es) * | 2018-10-12 | 2021-08-16 | Serum Inst Of India Private Ltd | Composicion de vacuna combinada que comprende dosis reducidas del virus inactivado de la polio y metodo de preparacion de la misma. |
| JOP20200214A1 (ar) | 2019-09-03 | 2021-03-03 | Serum Institute Of India Pvt Ltd | تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008536515A (ja) | 2005-04-18 | 2008-09-11 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド | ワクチンの調製のためのｂ型肝炎ウイルス表面抗原の発現 |
| US8945582B2 (en) * | 2006-09-07 | 2015-02-03 | Glaxosmithkline Biologicals S.A. | Vaccine |
| PE20100365A1 (es) * | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion |
| CA2763359C (en) | 2009-05-12 | 2021-07-27 | Baoming Jiang | New human rotavirus strains and vaccines |
| EP3459562B1 (en) * | 2011-01-05 | 2024-03-20 | Bharat Biotech International Limited | A combination heptavalent vaccine |
| WO2012117377A1 (en) * | 2011-03-02 | 2012-09-07 | Novartis Ag | Combination vaccines with lower doses of antigen and/or adjuvant |
| SI3204494T1 (sl) * | 2014-10-07 | 2020-08-31 | Serum Institute Of India Private Limited | Izboljšane metode za neaktivacijo poliovirusa, adjuvans adsorpcije |
| SG11201900365WA (en) * | 2016-08-26 | 2019-02-27 | Serum Institute Of India Pvt Ltd | Multivalent vaccine composition |
-
2017
- 2017-08-24 SG SG11201900365WA patent/SG11201900365WA/en unknown
- 2017-08-24 PE PE2019000409A patent/PE20200004A1/es unknown
- 2017-08-24 US US16/327,513 patent/US11235054B2/en active Active
- 2017-08-24 KR KR1020197008377A patent/KR102607295B1/ko active Active
- 2017-08-24 CU CU2019000013A patent/CU24682B1/es unknown
- 2017-08-24 UA UAA201902890A patent/UA129115C2/uk unknown
- 2017-08-24 CN CN201780052380.5A patent/CN110691611A/zh active Pending
- 2017-08-24 PH PH1/2019/500404A patent/PH12019500404B1/en unknown
- 2017-08-24 CA CA3032901A patent/CA3032901A1/en active Pending
- 2017-08-24 EA EA201900117A patent/EA201900117A1/ru unknown
- 2017-08-24 WO PCT/IB2017/055100 patent/WO2018037365A1/en not_active Ceased
- 2017-08-24 MY MYPI2019001011A patent/MY191163A/en unknown
- 2017-08-24 MX MX2019001780A patent/MX2019001780A/es unknown
- 2017-08-24 EP EP17783992.5A patent/EP3503917B1/en active Active
- 2017-08-24 JP JP2019532214A patent/JP7384667B2/ja active Active
- 2017-08-24 IL IL264605A patent/IL264605B2/en unknown
- 2017-08-24 AU AU2017316768A patent/AU2017316768B2/en active Active
-
2021
- 2021-07-16 JP JP2021118038A patent/JP2021181445A/ja active Pending
-
2023
- 2023-10-06 JP JP2023174503A patent/JP2024009899A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2019001780A (es) | 2020-01-13 |
| PH12019500404A1 (en) | 2020-01-20 |
| PH12019500404B1 (en) | 2024-05-15 |
| AU2017316768B2 (en) | 2024-04-11 |
| JP2021181445A (ja) | 2021-11-25 |
| EA201900117A1 (ru) | 2019-09-30 |
| BR112019003419A2 (pt) | 2019-05-21 |
| AU2017316768A1 (en) | 2019-04-11 |
| NZ751127A (en) | 2025-08-29 |
| EP3503917B1 (en) | 2024-07-03 |
| IL264605B2 (en) | 2023-04-01 |
| US11235054B2 (en) | 2022-02-01 |
| US20190175722A1 (en) | 2019-06-13 |
| WO2018037365A1 (en) | 2018-03-01 |
| CU20190013A7 (es) | 2019-10-04 |
| JP2024009899A (ja) | 2024-01-23 |
| KR20190142311A (ko) | 2019-12-26 |
| SG11201900365WA (en) | 2019-02-27 |
| IL264605B (en) | 2022-12-01 |
| IL264605A (en) | 2019-02-28 |
| CU24682B1 (es) | 2023-10-06 |
| EP3503917A1 (en) | 2019-07-03 |
| MY191163A (en) | 2022-06-03 |
| PE20200004A1 (es) | 2020-01-06 |
| JP2019526635A (ja) | 2019-09-19 |
| JP7384667B2 (ja) | 2023-11-21 |
| CN110691611A (zh) | 2020-01-14 |
| WO2018037365A8 (en) | 2018-09-20 |
| CA3032901A1 (en) | 2018-03-01 |
| KR102607295B1 (ko) | 2023-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU785433B2 (en) | Combined vaccines comprising hepatitis B surface antigen and other antigens | |
| TWI786153B (zh) | 具有改善之安定性、增強之免疫原性及降低之反應原性的免疫原性組成物和其製備方法 | |
| US8551451B2 (en) | Combination vaccine with acellular pertussis | |
| CN103442730B (zh) | 组合七价疫苗 | |
| CA2963897C (en) | Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof | |
| CN102196817B (zh) | 具有全细胞百日咳的联合疫苗 | |
| JP2024009899A (ja) | 多価ワクチン組成物 | |
| TWI880080B (zh) | 六合一液狀疫苗組成物 | |
| EA043682B1 (ru) | Комбинированная вакцина и способ её производства (варианты) | |
| RU2287344C2 (ru) | Комбинированная вакцина на основе поверхностного антигена вируса гепатита в, способ ее получения и способ предупреждения инфекции гепатита в у человека | |
| TW202038995A (zh) | 多價疫苗組合物 | |
| BR112019003419B1 (pt) | Vacina combinada e processo de fabricação de uma vacina combinada | |
| EA047205B1 (ru) | Состав полностью жидкой комбинированной вакцины с повышенной стабильностью, усиленной иммуногенностью и уменьшенной реактогенностью и способ её получения | |
| OA20569A (en) | Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof. | |
| HK1241920A1 (en) | Improved methods for poliovirus inactivation, adjuvant adsorption | |
| HK1241920B (en) | Improved methods for poliovirus inactivation, adjuvant adsorption |